{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T03:15:19Z","timestamp":1788318919941,"version":"build-2803163510"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T00:00:00Z","timestamp":1705881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T00:00:00Z","timestamp":1705881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Postgraduate Research & Practice Innovation Program of Jiangsu Province","award":["SJCX21_0622"],"award-info":[{"award-number":["SJCX21_0622"]}]},{"name":"Jiangsu Province Capability Improvement Project through Science, Technology and Education","award":["ZDXK202222"],"award-info":[{"award-number":["ZDXK202222"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gastric Cancer"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s10120-023-01463-5","type":"journal-article","created":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T04:02:18Z","timestamp":1705896138000},"page":"275-291","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["N6-methyladenosine-modified MIB1 promotes stemness properties and peritoneal metastasis of gastric cancer cells by ubiquitinating DDX3X"],"prefix":"10.1007","volume":"27","author":[{"given":"Peng","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanghui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shansong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialun","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyuan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zetian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peicheng","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawei","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zekuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diancai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,22]]},"reference":[{"key":"1463_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"1463_CR2","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1200\/JCO.2014.60.1799","volume":"33","author":"MA Shah","year":"2015","unstructured":"Shah MA. Update on metastatic gastric and esophageal cancers. J Clin Oncol. 2015;33:1760\u20139.","journal-title":"J Clin Oncol"},{"key":"1463_CR3","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/ijc.28373","volume":"134","author":"I Thomassen","year":"2014","unstructured":"Thomassen I, van Gestel YR, van Ramshorst B, Luyer MD, Bosscha K, Nienhuijs SW, et al. Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors. Int J Cancer. 2014;134:622\u20138.","journal-title":"Int J Cancer"},{"key":"1463_CR4","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1159\/000096002","volume":"52","author":"S Ishizone","year":"2006","unstructured":"Ishizone S, Maruta F, Saito H, Koide N, Sugiyama A, Nakayama J, et al. Efficacy of S-1 for patients with peritoneal metastasis of gastric cancer. Chemotherapy. 2006;52:301\u20137.","journal-title":"Chemotherapy"},{"key":"1463_CR5","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/annonc\/mdz001","volume":"30","author":"D Dong","year":"2019","unstructured":"Dong D, Tang L, Li ZY, Fang MJ, Gao JB, Shan XH, et al. Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer. Ann Oncol. 2019;30:431\u20138.","journal-title":"Ann Oncol"},{"key":"1463_CR6","doi-asserted-by":"publisher","first-page":"6829","DOI":"10.3748\/wjg.v22.i30.6829","volume":"22","author":"M Kanda","year":"2016","unstructured":"Kanda M, Kodera Y. Molecular mechanisms of peritoneal dissemination in gastric cancer. World J Gastroenterol. 2016;22:6829\u201340.","journal-title":"World J Gastroenterol"},{"key":"1463_CR7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/nchembio.2580","volume":"14","author":"MG Ubiquitination","year":"2018","unstructured":"Ubiquitination MG. Trashing the CIA. Nat Chem Biol. 2018;14:199.","journal-title":"Nat Chem Biol"},{"key":"1463_CR8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1146\/annurev-cellbio-100617-062802","volume":"34","author":"E Oh","year":"2018","unstructured":"Oh E, Akopian D, Rape M. Principles of ubiquitin-dependent signaling. Annu Rev Cell Dev Biol. 2018;34:137\u201362.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"1463_CR9","doi-asserted-by":"publisher","first-page":"5754","DOI":"10.3390\/ijms22115754","volume":"22","author":"T Zou","year":"2021","unstructured":"Zou T, Lin Z. The involvement of ubiquitination machinery in cell cycle regulation and cancer progression. Int J Mol Sci. 2021;22:5754.","journal-title":"Int J Mol Sci"},{"key":"1463_CR10","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s41418-021-00922-9","volume":"29","author":"JZ Roberts","year":"2022","unstructured":"Roberts JZ, Crawford N, Longley DB. The role of ubiquitination in apoptosis and necroptosis. Cell Death Differ. 2022;29:272\u201384.","journal-title":"Cell Death Differ"},{"key":"1463_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/cdd.2012.72","volume":"20","author":"S Shaid","year":"2013","unstructured":"Shaid S, Brandts CH, Serve H, Dikic I. Ubiquitination and selective autophagy. Cell Death Differ. 2013;20:21\u201330.","journal-title":"Cell Death Differ"},{"key":"1463_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41392-020-0107-0","volume":"5","author":"L Deng","year":"2020","unstructured":"Deng L, Meng T, Chen L, Wei W, Wang P. The role of ubiquitination in tumorigenesis and targeted drug discovery. Signal Transduct Target Ther. 2020;5:11.","journal-title":"Signal Transduct Target Ther"},{"key":"1463_CR13","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12943-020-01262-x","volume":"19","author":"T Sun","year":"2020","unstructured":"Sun T, Liu Z, Yang Q. The role of ubiquitination and deubiquitination in cancer metabolism. Mol Cancer. 2020;19:146.","journal-title":"Mol Cancer"},{"key":"1463_CR14","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1038\/s41388-022-02316-8","volume":"41","author":"P Gao","year":"2022","unstructured":"Gao P, Hao J-L, Xie Q-W, Han G-Q, Xu B-B, Hu H, et al. PELO facilitates PLK1-induced the ubiquitination and degradation of Smad4 and promotes the progression of prostate cancer. Oncogene. 2022;41:2945\u201357.","journal-title":"Oncogene"},{"key":"1463_CR15","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1038\/s41388-021-01699-4","volume":"40","author":"Q Bie","year":"2021","unstructured":"Bie Q, Song H, Chen X, Yang X, Shi S, Zhang L, et al. IL-17B\/IL-17RB signaling cascade contributes to self-renewal and tumorigenesis of cancer stem cells by regulating Beclin-1 ubiquitination. Oncogene. 2021;40:2200\u201316.","journal-title":"Oncogene"},{"key":"1463_CR16","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1038\/s41467-019-09289-5","volume":"10","author":"F Yang","year":"2019","unstructured":"Yang F, Xu J, Li H, Tan M, Xiong X, Sun Y. FBXW2 suppresses migration and invasion of lung cancer cells via promoting \u03b2-catenin ubiquitylation and degradation. Nat Commun. 2019;10:1382.","journal-title":"Nat Commun"},{"key":"1463_CR17","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1172\/JCI65703","volume":"123","author":"BJ Capoccia","year":"2013","unstructured":"Capoccia BJ, Jin RU, Kong Y-Y, Peek RM, Fassan M, Rugge M, et al. The ubiquitin ligase Mindbomb 1 coordinates gastrointestinal secretory cell maturation. J Clin Investig. 2013;123:1475\u201391.","journal-title":"J Clin Investig"},{"key":"1463_CR18","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.sbi.2016.05.012","volume":"41","author":"B Guo","year":"2016","unstructured":"Guo B, McMillan BJ, Blacklow SC. Structure and function of the Mind bomb E3 ligase in the context of Notch signal transduction. Curr Opin Struct Biol. 2016;41:38\u201345.","journal-title":"Curr Opin Struct Biol"},{"key":"1463_CR19","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.1002\/1878-0261.12955","volume":"15","author":"B Zhang","year":"2021","unstructured":"Zhang B, Cheng X, Zhan S, Jin X, Liu T. MIB1 upregulates IQGAP1 and promotes pancreatic cancer progression by inducing ST7 degradation. Mol Oncol. 2021;15:3062\u201375.","journal-title":"Mol Oncol"},{"key":"1463_CR20","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1158\/1541-7786.MCR-21-0342","volume":"20","author":"H Wang","year":"2022","unstructured":"Wang H, Huang Q, Xia J, Cheng S, Pei D, Zhang X, et al. The E3 ligase MIB1 promotes proteasomal degradation of NRF2 and sensitizes lung cancer cells to ferroptosis. Mol Cancer Res. 2022;20:253\u201364.","journal-title":"Mol Cancer Res"},{"key":"1463_CR21","doi-asserted-by":"publisher","first-page":"5814","DOI":"10.1038\/s41388-021-01978-0","volume":"40","author":"J Su","year":"2021","unstructured":"Su J, Wu G, Ye Y, Zhang J, Zeng L, Huang X, et al. NSUN2-mediated RNA 5-methylcytosine promotes esophageal squamous cell carcinoma progression via LIN28B-dependent GRB2 mRNA stabilization. Oncogene. 2021;40:5814\u201328.","journal-title":"Oncogene"},{"key":"1463_CR22","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1038\/s41388-022-02185-1","volume":"41","author":"Q-C Xu","year":"2022","unstructured":"Xu Q-C, Tien Y-C, Shi Y-H, Chen S, Zhu Y-Q, Huang X-T, et al. METTL3 promotes intrahepatic cholangiocarcinoma progression by regulating IFIT2 expression in an m6A-YTHDF2-dependent manner. Oncogene. 2022;41:1622\u201333.","journal-title":"Oncogene"},{"key":"1463_CR23","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.1016\/j.ymthe.2021.08.005","volume":"29","author":"J Ma","year":"2021","unstructured":"Ma J, Han H, Huang Y, Yang C, Zheng S, Cai T, et al. METTL1\/WDR4-mediated m7G tRNA modifications and m7G codon usage promote mRNA translation and lung cancer progression. Mol Ther. 2021;29:3422\u201335.","journal-title":"Mol Ther"},{"key":"1463_CR24","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1038\/s41388-023-02707-5","volume":"42","author":"K Liu","year":"2023","unstructured":"Liu K, Xu P, Lv J, Ge H, Yan Z, Huang S, et al. Peritoneal high-fat environment promotes peritoneal metastasis of gastric cancer cells through activation of NSUN2-mediated ORAI2 m5C modification. Oncogene. 2023;42:1980\u201393.","journal-title":"Oncogene"},{"key":"1463_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102955","volume":"59","author":"C Zhou","year":"2020","unstructured":"Zhou C, Zhang Z, Zhu X, Qian G, Zhou Y, Sun Y, et al. N6-Methyladenosine modification of the TRIM7 positively regulates tumorigenesis and chemoresistance in osteosarcoma through ubiquitination of BRMS1. EBioMedicine. 2020;59: 102955.","journal-title":"EBioMedicine"},{"key":"1463_CR26","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1158\/0008-5472.CAN-21-2106","volume":"82","author":"P Yadav","year":"2022","unstructured":"Yadav P, Subbarayalu P, Medina D, Nirzhor S, Timilsina S, Rajamanickam S, et al. M6A RNA methylation regulates histone ubiquitination to support cancer growth and progression. Cancer Res. 2022;82:1872\u201389.","journal-title":"Cancer Res"},{"key":"1463_CR27","first-page":"128","volume":"18","author":"J Bajaj","year":"2020","unstructured":"Bajaj J, Diaz E, Reya T. Stem cells in cancer initiation and progression. J Cell Biol. 2020.","journal-title":"J Cell Biol"},{"key":"1463_CR28","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nrc.2017.118","volume":"18","author":"T Brabletz","year":"2018","unstructured":"Brabletz T, Kalluri R, Nieto MA, Weinberg RA. EMT in cancer. Nat Rev Cancer. 2018;18:128\u201334.","journal-title":"Nat Rev Cancer"},{"key":"1463_CR29","doi-asserted-by":"publisher","first-page":"E7","DOI":"10.1038\/nature22963","volume":"547","author":"NM Aiello","year":"2017","unstructured":"Aiello NM, Brabletz T, Kang Y, Nieto MA, Weinberg RA, Stanger BZ. Upholding a role for EMT in pancreatic cancer metastasis. Nature. 2017;547:E7\u20138.","journal-title":"Nature"},{"key":"1463_CR30","doi-asserted-by":"publisher","first-page":"465","DOI":"10.7150\/ijbs.72218","volume":"19","author":"H Wu","year":"2023","unstructured":"Wu H, Xiang Z, Huang G, He Q, Song J, Dou R, et al. BGN\/FAP\/STAT3 positive feedback loop mediated mutual interaction between tumor cells and mesothelial cells contributes to peritoneal metastasis of gastric cancer. Int J Biol Sci. 2023;19:465\u201383.","journal-title":"Int J Biol Sci"},{"key":"1463_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.522","volume":"11","author":"C Wang","year":"2021","unstructured":"Wang C, Yang Z, Xu E, Shen X, Wang X, Li Z, et al. Apolipoprotein C-II induces EMT to promote gastric cancer peritoneal metastasis via PI3K\/AKT\/mTOR pathway. Clin Transl Med. 2021;11: e522.","journal-title":"Clin Transl Med"},{"key":"1463_CR32","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","volume":"29","author":"I Pastushenko","year":"2019","unstructured":"Pastushenko I, Blanpain C. EMT transition states during tumor progression and metastasis. Trends Cell Biol. 2019;29:212\u201326.","journal-title":"Trends Cell Biol"},{"key":"1463_CR33","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s13046-020-01690-z","volume":"39","author":"Q Tang","year":"2020","unstructured":"Tang Q, Chen J, Di Z, Yuan W, Zhou Z, Liu Z, et al. TM4SF1 promotes EMT and cancer stemness via the Wnt\/\u03b2-catenin\/SOX2 pathway in colorectal cancer. J Exp Clin Cancer Res. 2020;39:232.","journal-title":"J Exp Clin Cancer Res"},{"key":"1463_CR34","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nsmb.2780","volume":"21","author":"CE Berndsen","year":"2014","unstructured":"Berndsen CE, Wolberger C. New insights into ubiquitin E3 ligase mechanism. Nat Struct Mol Biol. 2014;21:301\u20137.","journal-title":"Nat Struct Mol Biol"},{"key":"1463_CR35","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2021108647","volume":"40","author":"S Brabletz","year":"2021","unstructured":"Brabletz S, Schuhwerk H, Brabletz T, Stemmler MP. Dynamic EMT: a multi-tool for tumor progression. EMBO J. 2021;40: e108647.","journal-title":"EMBO J"},{"key":"1463_CR36","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.tcb.2015.07.012","volume":"25","author":"X Ye","year":"2015","unstructured":"Ye X, Weinberg RA. Epithelial-mesenchymal plasticity: a central regulator of cancer progression. Trends Cell Biol. 2015;25:675\u201386.","journal-title":"Trends Cell Biol"},{"key":"1463_CR37","doi-asserted-by":"publisher","first-page":"3820","DOI":"10.3390\/cancers14153820","volume":"14","author":"M Secchi","year":"2022","unstructured":"Secchi M, Lodola C, Garbelli A, Bione S, Maga G. DEAD-box RNA helicases DDX3X and DDX5 as oncogenes or oncosuppressors: a network perspective. Cancers (Basel). 2022;14:3820.","journal-title":"Cancers (Basel)"},{"key":"1463_CR38","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3390\/ijms21010281","volume":"21","author":"T-C Lin","year":"2019","unstructured":"Lin T-C. DDX3X multifunctionally modulates tumor progression and serves as a prognostic indicator to predict cancer outcomes. Int J Mol Sci. 2019;21:281.","journal-title":"Int J Mol Sci"},{"key":"1463_CR39","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12943-021-01325-7","volume":"20","author":"J Mo","year":"2021","unstructured":"Mo J, Liang H, Su C, Li P, Chen J, Zhang B. DDX3X: structure, physiologic functions and cancer. Mol Cancer. 2021;20:38.","journal-title":"Mol Cancer"},{"key":"1463_CR40","doi-asserted-by":"publisher","first-page":"4492","DOI":"10.3390\/cancers14184492","volume":"14","author":"J Barankiewicz","year":"2022","unstructured":"Barankiewicz J, Salomon-Perzy\u0144ski A, Misiewicz-Krzemi\u0144ska I, Lech-Mara\u0144da E. CRL4CRBN E3 ligase complex as a therapeutic target in multiple myeloma. Cancers (Basel). 2022;14:4492.","journal-title":"Cancers (Basel)"},{"key":"1463_CR41","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S1534-5807(02)00409-4","volume":"4","author":"M Itoh","year":"2003","unstructured":"Itoh M, Kim C-H, Palardy G, Oda T, Jiang Y-J, Maust D, et al. Mind bomb is a ubiquitin ligase that is essential for efficient activation of Notch signaling by delta. Dev Cell. 2003;4:67\u201382.","journal-title":"Dev Cell"},{"key":"1463_CR42","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/cr.2011.199","volume":"22","author":"L-J Liu","year":"2012","unstructured":"Liu L-J, Liu T-T, Ran Y, Li Y, Zhang X-D, Shu H-B, et al. The E3 ubiquitin ligase MIB1 negatively regulates basal I\u03baB\u03b1 level and modulates NF-\u03baB activation. Cell Res. 2012;22:603\u20136.","journal-title":"Cell Res"},{"key":"1463_CR43","first-page":"1047","volume":"42","author":"J Ray","year":"2019","unstructured":"Ray J, Hoey C, Huang X, Jeon J, Taeb S, Downes MR, et al. MicroRNA-198 suppresses prostate tumorigenesis by targeting MIB1. Oncol Rep. 2019;42:1047\u201356.","journal-title":"Oncol Rep"},{"key":"1463_CR44","doi-asserted-by":"publisher","first-page":"11488","DOI":"10.1096\/fj.202000268RRR","volume":"34","author":"M Li","year":"2020","unstructured":"Li M, Liu B, Yi J, Yang Y, Wang J, Zhu W-G, et al. MIB1-mediated degradation of WRN promotes cellular senescence in response to camptothecin treatment. FASEB J. 2020;34:11488\u201397.","journal-title":"FASEB J"},{"key":"1463_CR45","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/s41419-021-04208-3","volume":"12","author":"Y Guo","year":"2021","unstructured":"Guo Y, Li Q, Zhao G, Zhang J, Yuan H, Feng T, et al. Loss of TRIM31 promotes breast cancer progression through regulating K48- and K63-linked ubiquitination of p53. Cell Death Dis. 2021;12:945.","journal-title":"Cell Death Dis"},{"key":"1463_CR46","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41420-022-01204-0","volume":"8","author":"L Cao","year":"2022","unstructured":"Cao L, Liu X, Zheng B, Xing C, Liu J. Role of K63-linked ubiquitination in cancer. Cell Death Discov. 2022;8:410.","journal-title":"Cell Death Discov"},{"key":"1463_CR47","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1146\/annurev-pathol-012615-044438","volume":"11","author":"D Nassar","year":"2016","unstructured":"Nassar D, Blanpain C. Cancer stem cells: basic concepts and therapeutic implications. Annu Rev Pathol. 2016;11:47\u201376.","journal-title":"Annu Rev Pathol"},{"key":"1463_CR48","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.stem.2014.02.002","volume":"14","author":"T Oskarsson","year":"2014","unstructured":"Oskarsson T, Batlle E, Massagu\u00e9 J. Metastatic stem cells: sources, niches, and vital pathways. Cell Stem Cell. 2014;14:306\u201321.","journal-title":"Cell Stem Cell"},{"key":"1463_CR49","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.mehy.2009.03.055","volume":"73","author":"L Cao","year":"2009","unstructured":"Cao L, Hu X, Zhang Y. Omental milky spots\u2013highly efficient \u201cnatural filter\u201d for screening gastric cancer stem cells. Med Hypotheses. 2009;73:1017\u20138.","journal-title":"Med Hypotheses"},{"key":"1463_CR50","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4149\/neo_2011_01_20","volume":"58","author":"L Cao","year":"2011","unstructured":"Cao L, Hu X, Zhang Y, Sun XT. Omental milky spots in screening gastric cancer stem cells. Neoplasma. 2011;58:20\u20136.","journal-title":"Neoplasma"},{"key":"1463_CR51","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1093\/jnci\/djp535","volume":"102","author":"ZA Rasheed","year":"2010","unstructured":"Rasheed ZA, Yang J, Wang Q, Kowalski J, Freed I, Murter C, et al. Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma. J Natl Cancer Inst. 2010;102:340\u201351.","journal-title":"J Natl Cancer Inst"},{"key":"1463_CR52","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1476-4598-13-15","volume":"13","author":"Q Ding","year":"2014","unstructured":"Ding Q, Miyazaki Y, Tsukasa K, Matsubara S, Yoshimitsu M, Takao S. CD133 facilitates epithelial-mesenchymal transition through interaction with the ERK pathway in pancreatic cancer metastasis. Mol Cancer. 2014;13:15.","journal-title":"Mol Cancer"},{"key":"1463_CR53","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/bcr2789","volume":"13","author":"CD May","year":"2011","unstructured":"May CD, Sphyris N, Evans KW, Werden SJ, Guo W, Mani SA. Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression. Breast Cancer Res. 2011;13:202.","journal-title":"Breast Cancer Res"},{"key":"1463_CR54","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1002\/ijc.26311","volume":"129","author":"C Scheel","year":"2011","unstructured":"Scheel C, Weinberg RA. Phenotypic plasticity and epithelial-mesenchymal transitions in cancer and normal stem cells? Int J Cancer. 2011;129:2310\u20134.","journal-title":"Int J Cancer"},{"key":"1463_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002218","volume":"7","author":"IM Shapiro","year":"2011","unstructured":"Shapiro IM, Cheng AW, Flytzanis NC, Balsamo M, Condeelis JS, Oktay MH, et al. An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype. PLoS Genet. 2011;7: e1002218.","journal-title":"PLoS Genet"},{"key":"1463_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2020.100773","volume":"13","author":"D Ribatti","year":"2020","unstructured":"Ribatti D, Tamma R, Annese T. Epithelial-mesenchymal transition in cancer: a historical overview. Transl Oncol. 2020;13: 100773.","journal-title":"Transl Oncol"},{"key":"1463_CR57","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.omtn.2021.02.003","volume":"23","author":"T Pan","year":"2021","unstructured":"Pan T, Yu Z, Jin Z, Wu X, Wu A, Hou J, et al. Tumor suppressor lnc-CTSLP4 inhibits EMT and metastasis of gastric cancer by attenuating HNRNPAB-dependent Snail transcription. Mol Ther Nucleic Acids. 2021;23:1288\u2013303.","journal-title":"Mol Ther Nucleic Acids"},{"key":"1463_CR58","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.7150\/ijbs.73491","volume":"18","author":"L Shen","year":"2022","unstructured":"Shen L, Zhang J, Xu M, Zheng Y, Wang M, Yang S, et al. DDX3 acts as a tumor suppressor in colorectal cancer as loss of DDX3 in advanced cancer promotes tumor progression by activating the MAPK pathway. Int J Biol Sci. 2022;18:3918\u201333.","journal-title":"Int J Biol Sci"},{"key":"1463_CR59","first-page":"287","volume":"20","author":"W Wang","year":"2021","unstructured":"Wang W, Jia M, Zhao C, Yu Z, Song H, Qin Y, et al. RNF39 mediates K48-linked ubiquitination of DDX3X and inhibits RLR-dependent antiviral immunity. Sci Adv. 2021.","journal-title":"Sci Adv."},{"key":"1463_CR60","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s12967-022-03483-8","volume":"20","author":"Y Pan","year":"2022","unstructured":"Pan Y, Zhu Y, Zhang J, Jin L, Cao P. A feedback loop between GATA2-AS1 and GATA2 promotes colorectal cancer cell proliferation, invasion, epithelial-mesenchymal transition and stemness via recruiting DDX3X. J Transl Med. 2022;20:287.","journal-title":"J Transl Med"},{"key":"1463_CR61","doi-asserted-by":"publisher","first-page":"28637","DOI":"10.1038\/srep28637","volume":"6","author":"H-K Li","year":"2016","unstructured":"Li H-K, Mai R-T, Huang H-D, Chou C-H, Chang Y-A, Chang Y-W, et al. DDX3 represses stemness by epigenetically modulating tumor-suppressive miRNAs in hepatocellular carcinoma. Sci Rep. 2016;6:28637.","journal-title":"Sci Rep"},{"key":"1463_CR62","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12943-020-01172-y","volume":"19","author":"M Chen","year":"2020","unstructured":"Chen M, Wong C-M. The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis. Mol Cancer. 2020;19:44.","journal-title":"Mol Cancer"},{"key":"1463_CR63","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s41418-022-01107-8","volume":"30","author":"Z Gao","year":"2023","unstructured":"Gao Z, Li C, Sun H, Bian Y, Cui Z, Wang N, et al. N6-methyladenosine-modified USP13 induces pro-survival autophagy and imatinib resistance via regulating the stabilization of autophagy-related protein 5 in gastrointestinal stromal tumors. Cell Death Differ. 2023;30:544\u201359.","journal-title":"Cell Death Differ"}],"container-title":["Gastric Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-023-01463-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10120-023-01463-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-023-01463-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T18:09:24Z","timestamp":1764266964000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10120-023-01463-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,22]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["1463"],"URL":"https:\/\/doi.org\/10.1007\/s10120-023-01463-5","relation":{},"ISSN":["1436-3291","1436-3305"],"issn-type":[{"value":"1436-3291","type":"print"},{"value":"1436-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,22]]},"assertion":[{"value":"15 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures conformed to the ethical standards of the responsible committee on human experimentation and to the Helsinki Declaration of 1964 and later versions. Informed consent or the equivalent consent was obtained from all patients included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}